Latest advances in antiaging medicine
Terry Grossman
Views about aging are changing rapidly. Rapid progress is being made in our ability to modify the aging process and in increasing average lifespan.
The leading causes of death (cardiovascular disease, cancer, lung disease, diabetes) are the end result of decades-long processes. With current knowledge assisted by healthy lifestyle choices, it is possible to delay the onset of these diseases. For example, emerging genomics technology will allow individuals to establish personalized programs, while early detection of heart disease and cancer will contribute to longevity.
In the near future, biotechnological therapies involving stem cells, recombinant DNA, proteomics, therapeutic cloning and gene-based therapies are expected to play major roles in promoting successful aging.
We are at the threshold of artificial intelligence (AI) and nanotechnology (NT). AI will allow for a merging of our biological thinking with advanced forms of non-biological intelligence to vastly expand our ability to think, create and experience.
NT will ultimately allow us to build devices able to build molecules much like our current cellular machinery does, one atom at a time. For example, intelligent nanobots that can course through our blood stream, bodily organs and brain with the goal of keeping us healthy and nanobiotic red blood cells which will allow you to go for hours without oxygen.
It is the goal of today’s antiaging medicine to forestall disease and aging long enough for people to utilize the powerful biotechnology and nanotechnology therapies that will be developed over the decades ahead. These future therapies have the potential to greatly extend longevity.
